Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept study published online.

Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Bone is not the inert structure we often imagine. It's alive, adapting daily to load-bearing and impact. But with over 200 ...

This month: shingles vaccine cuts CV events, brain injury impacts stroke risk, food insecurity’s health legacy, and more.

In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...